This inventor holds 2 USPTO granted patents. Top assignee: Other. Active years: 1998-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 834,513 Years Active: 1998-1999
Title: Ian A York: Innovator in Viral Gene Therapy
Introduction
Ian A York is a notable inventor based in Hamilton, Canada. He has made significant contributions to the field of viral gene therapy, particularly through his work on Herpes Simplex Virus (HSV) proteins. With a total of 2 patents, his innovations focus on enhancing the effectiveness of viral gene therapy vectors.
Latest Patents
York's latest patents include groundbreaking inventions related to HSV proteins. The first patent, titled "HSV proteins for inhibiting recognition by cytotoxic T lymphocytes," describes the use of HSV immediate early proteins ICP47 or IE12. This invention aims to inhibit the presentation of viral and cellular antigens associated with major histocompatibility class I (MHC class I) proteins to CD8+ T lymphocytes. By doing so, it effectively increases infective persistence, which can improve the utility of viral gene therapy vectors. The patent also outlines a method for inhibiting recognition of a cell by cytotoxic T lymphocytes through the introduction of isolated proteins of ICP47 or IE12.
The second patent, "Vector, element and method for inhibiting immune recognition," similarly focuses on the use of HSV immediate early protein ICP47. This invention not only aims to inhibit the presentation of antigens but also pertains to methods for treating herpesvirus infections. It discusses the inhibition of ICP47 protein expression to enhance immune recognition of infected cells. Furthermore, it explores methods for treating autoimmune diseases and other conditions by introducing ICP47 or its homologues into patient cells.
Career Highlights
Throughout his career, Ian A York has demonstrated a commitment to advancing the field of viral gene therapy. His innovative approaches have the potential to significantly impact the treatment of various viral infections and autoimmune diseases.
Collaborations
York collaborates with fellow innovator David C Johnson, contributing to the development of new therapeutic strategies in their field.
Conclusion
Ian A York's contributions to the field of viral gene therapy through his patents on HSV proteins highlight his role as a leading inventor. His work not only enhances the understanding of immune responses but also paves the way for innovative treatments in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile